Parosmia

• CLINICAL_TRIALS research · 2026-04-24
  Clinical Trial Update: Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

  This clinical trial update outlines a pilot study using electrobulbogram (EBG), fMRI, and diffusion-weighted imaging to explore central brai…

• CLINICAL_TRIALS trial_result · 2026-03-27
  Clinical Trial Update: Multimodal Chewing Gum Flavour Training to Aid Flavour Perception Recovery - a Pilot Study. [NA]

  This completed pilot study evaluated multimodal chewing gum flavor training as a potential intervention to aid recovery of flavor perception…

• CLINICAL_TRIALS research · 2024-12-17
  Clinical Trial Update: Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19 [NA]

  A clinical trial is evaluating olfactory training as a treatment for olfactory dysfunction following COVID-19 and is currently recruiting.

• CLINICAL_TRIALS research · 2024-11-22
  Clinical Trial Update: Randomized Clinical Trial of Intranasal Injection of Platelet-Rich Plasma for Treatment of Parosmia [NA]

  This clinical trial update describes a randomized study evaluating intranasal platelet-rich plasma injections for the treatment of parosmia,…

• CLINICAL_TRIALS research · 2024-10-23
  Clinical Trial Update: Stellate Ganglion Block With Lidocaine for the Treatment of COVID-19-Induced Parosmia [Phase 3]

  Phase 3 clinical trial evaluating stellate ganglion block with lidocaine for treating COVID-19-induced parosmia is currently recruiting.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-11-07
  Clinical Trial Update: Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction [Phase 1, Phase 2]

  This clinical trial update reports the completion and posting of results for a Phase 1/2 study of Stellate Ganglion Block to treat COVID-19-…

• CLINICAL_TRIALS trial_result · 2022-05-11
  Clinical Trial Update: Vitamin D Nasal Drops in Post COVID-19 Parosmia [Phase 2]

  Phase 2 clinical trial evaluating vitamin D nasal drops for post-COVID-19 parosmia.

• CLINICAL_TRIALS trial_result · 2022-05-11
  Clinical Trial Update: Ivermectin Nasal Drops in Post COVID-19 Parosmia [Phase 2]

  Phase 2 clinical trial evaluating ivermectin nasal drops for post-COVID-19 parosmia is ongoing with unknown status.